Dezhan Healthcare Company Limited (SHE:000813)

China flag China · Delayed Price · Currency is CNY
4.310
+0.120 (2.86%)
Sep 26, 2025, 3:04 PM CST
2.86%
Market Cap8.77B
Revenue (ttm)384.52M
Net Income (ttm)-73.49M
Shares Out2.04B
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume99,856,841
Average Volume108,493,406
Open4.180
Previous Close4.190
Day's Range4.130 - 4.480
52-Week Range2.550 - 5.260
Beta0.26
RSI51.49
Earnings DateOct 24, 2025

About Dezhan Healthcare Company

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It is also involved in the provision of biological peptides, industrial hemp, and medica... [Read more]

Sector Healthcare
Founded 1980
Employees 1,054
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000813
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.